Iovance Biotherapeutics is trading at $8.08, down -4.15% on September 10, 2026, amid declining major U.S. indexes and heightened rate concerns after hotter-than-expected producer inflation.
- No clear negative company-specific announcement was identified.
- Iovance is scheduled to present at the Wells Fargo Healthcare Conference at 11:00 a.m. ET; the announcement does not explain the decline.
- Rising oil prices and geopolitical tensions are adding to broader risk-off pressure. [Event ID: 6aa2b94d098edf0569c721c8]